Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
- 31 March 2004
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 190 (3) , 769-774
- https://doi.org/10.1016/j.ajog.2003.09.067
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- First‐trimester screening for aneuploidy with fetal nuchal translucency in a United States populationUltrasound in Obstetrics & Gynecology, 2003
- One‐stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15 030 pregnanciesUltrasound in Obstetrics & Gynecology, 2002
- Genetic SonographyJournal of Ultrasound in Medicine, 2002
- Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and olderObstetrics & Gynecology, 2001
- Efficacy of screening for fetal down syndrome in the United States from 1974 to 1997Obstetrics & Gynecology, 2000
- First-trimester screening for aneuploidy: Research or standard of care?American Journal of Obstetrics and Gynecology, 2000
- Integrated Screening for Down's Syndrome Based on Tests Performed during the First and Second TrimestersNew England Journal of Medicine, 1999
- UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestationThe Lancet, 1998
- Reducing the Need for Amniocentesis in Women 35 Years of Age or Older with Serum Markers for ScreeningNew England Journal of Medicine, 1994
- Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersNew England Journal of Medicine, 1992